Mesuximide or methsuximide
- Level
- Commodity
- Parent
- 51141500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51141521This classification denotes an anticonvulsant agent with the molecular formula C12H13NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 0G76K8X6C0, chemically known as 2,5-pyrrolidinedione,1,3-dimethyl-3-phenyl- but more generally known as mesuximide, which bears US NIH Compound Identifier 6476. European Medicines Agency schedules Mesuximide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08797MIG. The term MESUXIMIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules mesuximide in its Anatomical Therapeutic Chemical (ATC) Classification. Methsuximide bears US NLM identifiers UMLS ID C0109002 and NCI Concept Code C47613. MESUXIMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: CC1(CC(=O)N(C1=O)C)C2=CC=CC=C2.
Same parent
Under 51141500 · 80Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.